xerava
Generic: eravacycline
xerava: developed by 3 companies · 1 FDA decision. Updated within the last hour.
Development Pipeline (3)
| Company | Phase |
|---|---|
| Innoviva, Inc. (INVA) | Approved |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | Approved |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) | Approved |
FDA Decisions
Approval(TTPH)
Frequently asked questions
Who is developing xerava?
xerava is being developed by Innoviva, Inc., LA JOLLA PHARMACEUTICAL CO, TETRAPHASE PHARMACEUTICALS INC.
What is xerava's latest FDA decision?
The most recent tracked FDA decision for xerava is Approval, dated August 27, 2018.
Get deeper analysis on xerava
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis